RNA Outsourcing Resources

1. Potent Immune Response With Vernal's LNP-mRNAs 4/26/2024

   As mRNA medicine continues to evolve, understand how trusted manufacturing partners will continue to play a pivotal role in translating innovative concepts into clinical reality.

2. When Is A New Biologic Ready For GMP Production? 1/17/2023

   While there are differences by modality in DNA, RNA, and protein, find general recommendations on questions to prepare for and steps to consider when preparing to move to clinic.

3. Consolidating The Supply Chain For mRNA 2/12/2024

   Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.

4. Pharmaceutical Supply Chain Management Best Practices 9/13/2024

   Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

5. Gene And Cell Therapy: Planning For Manufacturing Success Early 1/16/2023

   As gene therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations, explore how to optimize plasmid production and reach patients with efficiency.

6. Getting CMC Right For Emerging Technologies 12/20/2023

   Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.

7. Is Not Using A CDMO Slowing Down Your Process Development? 4/27/2020

   Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful but also improve your chances of getting to market sooner.

8. Improvement Of Self-Amplifying RNA Quality And Potency With IVT Optimization 1/28/2025

   Explore our study on optimizing In-Vitro Transcription (IVT) conditions for self-amplifying RNAs to achieve high yields, low residual dsRNA, and improved potency, and learn how these advancements can enhance RNA-based therapies.

9. Lessons In Scaling Lipids Production And Purification 12/13/2021

   The speed at which the pharmaceutical industry is now developing and manufacturing mRNA drug products at large scale is astounding, yet it has highlighted supply chain vulnerabilities to make the required pharmaceutical ingredients such as lipids.

10. Supercharge Your Supply Chain: Harness AI To Gain Competitive Advantage

    The success of CGTs hinges upon adherence to specific logistics protocols. Learn how the integration of AI in the pharma supply chain is poised to enhance visibility, efficiency, and compliance.